2023 Annual Meeting | H108 - How to Build a Research Site at Your Practice (Practice and Policy Hub)

Date Sunday 04/23/23

Time 04:30 PM - 05:00 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Hubs (Practice and Policy)

Director(s) Brad C. Klein, MD, MBA, FAAN, Belinda A. Savage-Edwards, MD, FAAN

Topic(s) Practice, Policy, and Ethics

Learning Objectives Practices search for opportunities to grow, further help their patients, and increase revenues. Starting clinical trials can match those needs well and more! Starting a trial does not have to be intimidating, and it's not impossible. This presentation will help get you on the right path. Upon completion, participants should be able to understand how to start a clinical trial and identify the factors involved in clinical trials.

CME Available 0.50 CME credit

Program Tracks Business of Neurology

Recommended Audience Fellow, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Didactic

Event Timeline
04:30 PM - 05:00 PM EST	Speaker	How to Build a Research Site at Your Practice Brad C. Klein, MD, MBA, FAAN, Belinda A. Savage-Edwards, MD, FAAN

Faculty Disclosures
Brad C. Klein, MD, MBA, FAAN	Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biodelivery Science. The institution of Dr. Klein has received research support from AbbVie. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with AppsbyDocs, LLC. Dr. Klein has a non-compensated relationship as a Chair, Practice Management Committee with American Headache Society that is relevant to AAN interests or activities.
Belinda A. Savage-Edwards, MD, FAAN	The institution of Dr. Savage-Edwards has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Llly. The institution of Dr. Savage-Edwards has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharmaceutical. The institution of Dr. Savage-Edwards has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Association of Neurology Journal. The institution of Dr. Savage-Edwards has received research support from Eli LIlly Co.. The institution of Dr. Savage-Edwards has received research support from Amgen. The institution of Dr. Savage-Edwards has received research support from AbbVie.